AYTU
Price:
$2.47
Market Cap:
$14.75M
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2008-09-25
Stock Exchange
NASDAQ
Ticker
AYTU
According to Aytu BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 26.64M. This represents a change of 106.59% compared to the average of 12.90M of the last 4 quarters.
The mean historical Enterprise Value of Aytu BioPharma, Inc. over the last ten years is 12.13M. The current 26.64M Enterprise Value has changed 21.86% with respect to the historical average. Over the past ten years (40 quarters), AYTU's Enterprise Value was at its highest in in the March 2021 quarter at 117.80M. The Enterprise Value was at its lowest in in the December 2018 quarter at -7652051.00.
Average
12.13M
Median
4.31M
Minimum
-3551381.00
Maximum
62.60M
Discovering the peaks and valleys of Aytu BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.86%
Maximum Annual Enterprise Value = 62.60M
Minimum Annual Increase = -210.41%
Minimum Annual Enterprise Value = -3551381.00
Year | Enterprise Value | Change |
---|---|---|
2023 | -1280150.40 | -106.70% |
2022 | 19.11M | -69.47% |
2021 | 62.60M | 245.87% |
2020 | 18.10M | 361.58% |
2019 | 3.92M | -210.41% |
2018 | -3551381.00 | -175.61% |
2017 | 4.70M | 4.86% |
2016 | 94.66K | -104.21% |
2015 | -2245861.00 | -111.30% |
2014 | 19.87M | 5.54% |
The current Enterprise Value of Aytu BioPharma, Inc. (AYTU) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
26.81M
5-year avg
20.49M
10-year avg
12.13M
Aytu BioPharma, Inc.’s Enterprise Value is less than Aquestive Therapeutics, Inc. (477.76M), greater than Evoke Pharma, Inc. (-704123.00), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), greater than Guardion Health Sciences, Inc. (-1377671.00), greater than AcelRx Pharmaceuticals, Inc. (1.19M), less than Shionogi & Co., Ltd. (1.54T), greater than Sunshine Biopharma, Inc. (-7269610.00), less than Alimera Sciences, Inc. (362.58M), greater than China SXT Pharmaceuticals, Inc. (-7024388.00), greater than Shuttle Pharmaceuticals Holdings, Inc. (4.16M), less than Lifecore Biomedical, Inc. (282.57M), greater than Petros Pharmaceuticals, Inc. (3.78M), less than Ironwood Pharmaceuticals, Inc. (1.26B), less than Neptune Wellness Solutions Inc. (27.81M), greater than Flora Growth Corp. (13.49M), less than Jupiter Wellness, Inc. (45.30M), greater than Sonoma Pharmaceuticals, Inc. (2.24M), less than Esperion Therapeutics, Inc. (708.76M), less than Journey Medical Corporation (105.02M), less than Avadel Pharmaceuticals plc (1.32B),
Company | Enterprise Value | Market cap |
---|---|---|
477.76M | $450.75M | |
-704123.00 | $3.47M | |
-6593458674.00 | $7.25M | |
-1377671.00 | $13.45M | |
1.19M | $14.58M | |
1.54T | $12.63B | |
-7269610.00 | $3.66M | |
362.58M | $301.29M | |
-7024388.00 | $2.40M | |
4.16M | $3.70M | |
282.57M | $160.67M | |
3.78M | $3.60M | |
1.26B | $722.02M | |
27.81M | $906.41K | |
13.49M | $14.03M | |
45.30M | $49.33M | |
2.24M | $4.41M | |
708.76M | $341.43M | |
105.02M | $106.12M | |
1.32B | $1.31B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aytu BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aytu BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Aytu BioPharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Aytu BioPharma, Inc. (AYTU)?
What is the 3-year average Enterprise Value for Aytu BioPharma, Inc. (AYTU)?
What is the 5-year average Enterprise Value for Aytu BioPharma, Inc. (AYTU)?
How does the current Enterprise Value for Aytu BioPharma, Inc. (AYTU) compare to its historical average?